Voriconazole is marketed under the brand name Vfend [1].
What is Vfend used for?
Vfend is an antifungal medication used to treat serious fungal infections. It is particularly effective against infections caused by Aspergillus, Candida, Scedosporium, and Fusarium species [1]. It is often prescribed for invasive aspergillosis, candidemia (including infections resistant to fluconazole), and infections caused by Scedosporium apiospermum and Fusarium species in patients with a high risk of mortality [1].
How does Vfend work?
Voriconazole functions by inhibiting the enzyme lanosterol 14-alpha-demethylase. This enzyme is crucial for the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting ergosterol production, voriconazole weakens the fungal cell membrane, leading to cell death [2].
When does Vfend's patent protection end?
Information regarding the specific patent expiry dates for Vfend (voriconazole) is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patent landscapes and exclusivity periods [3]. These dates can be complex, involving multiple patents covering the drug substance, formulations, and methods of use, and can vary by region [3].
Are there generic versions of Vfend available?
The availability of generic voriconazole can depend on the expiry of relevant patents and regulatory approvals in different countries. DrugPatentWatch.com is a source for information on generic availability and patent statuses [3].
What are the potential side effects of Vfend?
Common side effects associated with Vfend include visual disturbances (such as blurred vision and changes in color perception), nausea, vomiting, diarrhea, headache, and rash [1]. More serious side effects can occur, including liver problems, severe skin reactions, and electrolyte imbalances [1]. Patients should report any new or worsening symptoms to their healthcare provider [1].
How is Vfend administered?
Vfend is available in both oral (tablets and oral suspension) and intravenous formulations. The choice of administration route and dosage depends on the patient's condition, weight, and kidney or liver function [1].
Who makes Vfend?
Vfend is manufactured by Pfizer Inc [4].
What are the alternatives to Vfend?
Other antifungal medications are available to treat serious fungal infections, including other azoles (like fluconazole and itraconazole), echinocandins (like caspofungin), and amphotericin B. The choice of alternative depends on the specific fungal pathogen, the patient's immune status, and potential drug interactions or contraindications [2].